Pages that link to "Q33243310"
Jump to navigation
Jump to search
The following pages link to Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes. (Q33243310):
Displaying 11 items.
- In Vitro Characterization of Human Peptide Transporter hPEPT1 Interactions and Passive Permeation Studies of Short Cationic Antimicrobial Peptides (Q33845130) (← links)
- Characterization of a liposome-based artificial skin membrane for in vitro permeation studies using Franz diffusion cell device (Q36118971) (← links)
- Method to screen substrates of apical sodium-dependent bile acid transporter (Q37065775) (← links)
- Modeling kinetics of subcellular disposition of chemicals. (Q37194304) (← links)
- Angiopep-2-conjugated poly(ethylene glycol)-co- poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats (Q37714094) (← links)
- Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology. (Q38946361) (← links)
- In vitro models to estimate drug penetration through the compromised stratum corneum barrier. (Q39885665) (← links)
- In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier. (Q42840452) (← links)
- In situ artificial membrane permeation assay under hydrodynamic control: permeability-pH profiles of warfarin and verapamil. (Q43070362) (← links)
- Development of phospholipid vesicle-based permeation assay models capable of evaluating percutaneous penetration enhancing effect (Q47748957) (← links)
- PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop (Q51137886) (← links)